SUBMIT AN ABSTRACT
On behalf of the Scientific Committee, thank you for submitting your work for presentation. Please take a moment to read the following simple guidelines.
The abstract submission deadline is January 4th, 2019.
All abstracts must be sent by e-mail to email@example.com by the abstract submission deadline.
ABSTRACT SUBMISSION GUIDELINES
- All submissions must be made by e-mail by January 4th, 2019.
- If an abstract is accepted for presentation, the first author must undertake to present it.
- All abstracts will initially be reviewed, graded and accepted or rejected by the Program Committee. The decision of the Committee is final.
- The presenting or senior author is required to register for the congress in order to have acceptance of the abstract confirmed.
Preparation of Abstracts
- All abstracts must be submitted in English.
- An abstract must have a short, specific title (containing no abbreviations) that indicates the nature of the investigation.
- Abstract must include all of the following subsections: Objectives and Hypothesis, Methods, Findings, and Conclusions.
- Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
- Use generic drug names.
- Standard abbreviations may be used without definition. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated.
- Do not include references, credits or grant support.
- Do not include the names or personal information of any patient participating in the study or trial.
- The body of the abstract must not exceed 2,500 characters (including spaces).
- Not more than one image or one table should be included in the abstract
- Abstracts will be considered for Poster Presentation
- Neurologic biomarkers (including EEG, neurophysiologic monitoring, neuroimaging, and serum markers)
- Translational neuroscience
- Neurologic prediction and prognostication
- Clinical informatics and bioinformatics relevant to acute neurological disorders
- Stroke including (ischemic stroke, ICH or SAH)
- Encephalopathy and delirium
- Traumatic brain injury
- Neurocritical care
- Intensive care medicine
Evaluation Process and Acceptance Letters
All submitted abstracts will be scored by the Scientific Committee following which the draft program will be drawn up. While scientific merit is the most important factor in evaluating an abstract, the program will also take into account other factors such as the innovation, relevance, geographic representation etc.
Acceptance letters will be sent by e-mail. Relevant information about your abstract’s presentation including the presentation date, time, presentation number will be included in the acceptance letters.
The presenting author of the abstract must be registered for the congress by January 21st 2019
Thank you for submitting your work for consideration. Please contact us directly should you have any specific enquiries about Scientific Program.
Kenes M+, Scientific Program Coordinator
Alida Enes, firstname.lastname@example.org